ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Qtern, Filmtabletten - 28
66040001 AstraZeneca AG
Qtern, Filmtabletten26.06.2017
  26.06.2017
Saxagliptin and Dapagliflozin (A10BD21) 
WHO-DDD 
07.06.20.28
07.06.20. 
B  
Yes 
IPCI
69.43Yes
    
10 %96.20
  
7680660400018Synthetika
7170142 
Composition
dapagliflozinum 10 mg ut dapagliflozinum propandiolum monohydricum, saxagliptinum 5 mg ut saxagliptini hydrochloridum, cellulosum microcristallinum, lactosum 40 mg, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, acidum hydrochloridum, natrii hydroxidum, E 171, E 172 (flavum), E 172 (rubrum), Drucktinte: E 132, lacca, pro compresso obducto corresp. natrium max. 0.91 mg.
Packungsbestandteile
Coated tablets 
 
Active AgentDose
Dapagliflozinum10 mg
Saxagliptinum5 mg
BAG: Active AgentDose
Dapagliflozinum10 mg
Saxagliptinum5 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
(Rubrum)  
Acidum Hydrochloridum  
Carmellosum Natricum Conexum  
Cellulosum Microcristallinum  
E 132 Drucktinte
E 171 color.
E 172 color.
Lacca  
Lactosum40 mg 
Macrogol3350  
Magnesii Stearas  
Sodium Hydroxide  
Poly(Alcohol Vinylicus) Überzug
Pro Compresso Obducto  
Silica Colloidalis Anhydrica  
Talcum  
 
Source
Data was imported : 04.12.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home